S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

FS KKR Capital Faces Securities Litigation Over Portfolio Losses

Institutional investors who held FS KKR Capital Corp. stock between May 8, 2024, and February 25, 2026, are being urged to evaluate their potential role as lead plaintiffs in a pending class action lawsuit following a combined $880 million decline in the firm’s investment portfolio fair value.

FS KKR Capital Faces Securities Litigation Over Portfolio Losses
Photo: Bio & News

The litigation targets alleged material misstatements by company officers regarding portfolio health and the sustainability of dividend distributions. Following corrective disclosures, FSK shares dropped 15.24% on February 26, 2026, closing at $11.29. The company subsequently slashed its quarterly dividend from $0.70 to $0.48 per share, citing rising non-accrual investments that exceeded industry averages.

Fiduciaries, including pension funds and asset managers, face scrutiny regarding their oversight of these holdings during the class period. The lawsuit notes that the company’s net asset value eroded by 14.1%, falling from $24.32 to $20.89 per share. For investors, the court-appointed lead plaintiff position offers direct oversight of litigation strategy and settlement negotiations. Legal counsel at Levi & Korsinsky, LLP noted that institutional participation is vital for ensuring accountability in these proceedings. The deadline for interested parties to apply for lead plaintiff status is July 6, 2026.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!